Moderna Edges Closer To Becoming A Mid-Stage Drug Development Company

 
• By Jessica Merrill
  
micro RNA (let7; pink) bound to mRNA (lin-41; cyan). miRNAs are small non-coding RNA molecules important for gene regulation and implicated in cancer, obesity and heart disease. - Illustration
Moderna is moving forward with mRNA clinical canidates • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from R&D

More from Scrip